A dermatologist explores strategies for managing adverse events in psoriasis treatment, with a specific focus on considerations and best practices for patients with skin of color.
Study Compares Dose Escalation with Biologics in Psoriasis
The Cutaneous Connection: An Inside Look of the Inclusive Atlas
Oral Zasocitinib Demonstrates Safety and Efficacy in Moderate to Severe Plaque Psoriasis
The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics
Patients With Psoriasis Demonstrate Higher Rates of Helicobacter Pylori Infection Versus Controls
Higher Risankizumab Adherence with New Injection Device